Navigation Links
NeurogesX to Present at UBS Global Life Sciences Conference
Date:9/17/2009

pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. Qutenza will be marketed in the European Union and certain countries in Eastern Europe, the Middle East and Africa, by Astellas Pharma Europe, Ltd. In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the U.S. Food and Drug Administration (FDA) which was accepted for filing by the FDA in December 2008 and has been given an extended Prescription Drug User Fee Act (PDUFA) date of November 16, 2009.

NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 has completed three Phase 1 studies and NeurogesX is currently planning the design and timing of this program.

NeurogesX' early stage product pipeline includes pre-clinical compounds, which are prodrugs of acetaminophen and various opioids. The company has evaluated these compounds in vitro and in vivo and is currently seeking development partners for these programs.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to the timing and outcome of regulatory decisions and label approval being sought or that may be obtained with respect to the NDA for Qutenza with the FDA, including the PDUFA date for the NDA; plans and timing for commercialization of Qutenza; and develop
'/>"/>

SOURCE NeurogesX
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NeurogesX to Present at Upcoming Fall Conferences
2. NeurogesX Appoints New Board Director and Audit Committee Chairman
3. NeurogesX Reports Second Quarter 2009 Results
4. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
5. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
6. NeurogesX Added to Russell 3000 Index
7. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
8. NeurogesX to Present at Needham Life Sciences Conference
9. NeurogesX Receives European Commission Approval for Qutenza(TM)
10. NeurogesX Reports First Quarter 2009 Results
11. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Alachua, Fla. (PRWEB) July 22, 2014 ... cyclodextrins for the pharmaceutical, medical device, cosmetics, and other ... Private Placement with a group of qualified private investors ... Pharmacia. , The transaction involved the ... Holdings issued 1,725,000 shares of Common Stock at a ...
(Date:7/22/2014)... Two new members were elected to the ... annual Shareholders Meeting on June 13: Kerry R. Benson, ... Group, and Stephen T. Zarrilli, President and CEO of ... of Michael A. DiPiano, Managing General Partner of New ... Jaffe, Esq., of Duane Morris LLP, as Director Emeritus. ...
(Date:7/22/2014)... Massachusetts e SHENZHEN , ... Co., LTD, (BGI Tech), una filiale di BGI, la ... lancio mondiale di un nuovo servizio di sequenziamento dell,intero ... di Complete Genomics. Complete Genomics, molto ... tecnologie di sequenziamento proprietarie con il 99.999% di precisione ...
(Date:7/22/2014)... In chemical and petrochemical plants, and ... The rapid rise of TDL analyzers over recent ... a core gas measurement technology, and their high ... gas analyzer technology of choice for many companies. ... processes have limited their application range. METTLER TOLEDO's ...
Breaking Biology Technology:CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the 10th Annual Needham ... p.m. Eastern Time in New York City.  Dr. Sands ...
... 2011 Transgenomic, Inc. (OTC Bulletin Board: ... discovered a novel sequencing technology, which the company has ... the limit of detection of standard Sanger Sequencing, enriches ... DNA) and can be run on standard Sanger Sequencing ...
... 2011 Morphotek®, Inc., a subsidiary of Eisai ... a collaboration and license agreement with Biocare Medical, ... to develop and commercialize an immunohistochemical (IHC) diagnostic ... detect human folate receptor alpha (FRA) with Biocare,s ...
Cached Biology Technology:Lexicon Pharmaceuticals to Present at the 10th Annual Needham Healthcare Conference 2Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1% 2Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1% 3Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1% 4Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues 2Morphotek®, Inc. Announces an Agreement with Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit for Detection of Folate Receptor Alpha in Malignant Tissues 3
(Date:7/22/2014)... mutations in prickle genes cause epilepsy, which in ... seizures over time. However, the mechanism responsible for ... University of Iowa study, published online July 14 ... of Sciences , reveals a novel pathway in ... the basic cellular mechanism that goes awry in ...
(Date:7/22/2014)... 14, 2014, by lightning from a weather system that moved ... fires: Stokes Fire, Gold Hikes Fire, French Creek Fire and ... now one larger fire. The fires are burning in timber ... acres in size. The present fire situation continues to ... firefighter safety is the priority on the Carlton Complex fires. ...
(Date:7/22/2014)... Genomes Project, aims to accelerate breeding for desired traits ... health and welfare. Results of the project,s first phase ... individual bulls whose direct descendants number in the tens ... Nature Genetics . , According to the researchers, breeding ... hereditary diseases and to improve the efficency of milk ...
Breaking Biology News(10 mins):UI study finds potential genetic link between epilepsy and neurodegenerative disorders 2Whole-genome sequencing of bulls in key beef and dairy breeds 2
... glass in the western United States have found that ... 12 million years ago, roughly 8 or 9 million ... implications not only for understanding the geologic history of ... "All the global climate models that are currently ...
... from Boston University School of Medicine (BUSM) have ... gene (Activating Enhancer-Binding Protein) result in the distinctive ... disorder is characterized by specific skin anomalies involving ... a typical facial appearance, and frequently cleft lip ...
... AUSTIN, TexasA newly created microbe produces cellulose that can ... from The University of Texas at Austin who say ... nations transportation fuel if production can be scaled up. ... R. Malcolm Brown Jr. and Dr. David Nobles Jr. ...
Cached Biology News:Sierra Nevada rose to current height earlier than thought, say Stanford geologists 2Sierra Nevada rose to current height earlier than thought, say Stanford geologists 3Sierra Nevada rose to current height earlier than thought, say Stanford geologists 4New source for biofuels discovered 2New source for biofuels discovered 3
Competitors to lower non-specific signal...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Biology Products: